KuibyshevAzot and DSM Form Two Joint Ventures for Engineering Plastics

KuibyshevAzot OJSC (KA), one of the leading chemicals companies in Russia, and Royal DSM, a global science-based firm, have formed two new joint ventures.

DSM Engineering Plastics owns a majority share in both the ventures, which are related to the manufacture of engineering plastics compounds in a facility based in Togliatti, Russia and sales and marketing of engineering plastics in Russia and other associates of Commonwealth of Independent States. The joint venture focuses on both high viscosity and compounds applications of polyamide 6 (PA6).

As part of the collaboration, KA has secured a license for DSM Fibre Intermediates' cyclohexanone technology. This technology will be used at KA's caprolactam facility in Togliatti to boost the production capacity and to address the increasing demand for cyclohexanone (polyamide 6 intermediate).

In addition, DSM Engineering Plastics has purchased 80% rights in the engineering plastics compounding facility situated at KA's Togliatti manufacturing site. DSM will receive royalty income for more than 15 years through the licensing agreement.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, February 09). KuibyshevAzot and DSM Form Two Joint Ventures for Engineering Plastics. AZoM. Retrieved on November 25, 2024 from https://www.azom.com/news.aspx?newsID=29788.

  • MLA

    Chai, Cameron. "KuibyshevAzot and DSM Form Two Joint Ventures for Engineering Plastics". AZoM. 25 November 2024. <https://www.azom.com/news.aspx?newsID=29788>.

  • Chicago

    Chai, Cameron. "KuibyshevAzot and DSM Form Two Joint Ventures for Engineering Plastics". AZoM. https://www.azom.com/news.aspx?newsID=29788. (accessed November 25, 2024).

  • Harvard

    Chai, Cameron. 2019. KuibyshevAzot and DSM Form Two Joint Ventures for Engineering Plastics. AZoM, viewed 25 November 2024, https://www.azom.com/news.aspx?newsID=29788.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.